Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
investment
Pharma
AstraZeneca plots NYSE listing amid UK industry pullback
The move will replace AZ’s existing U.S. listing of American Depositary Receipts on the Nasdaq, which simplify U.S. investing in foreign companies.
Fraiser Kansteiner
Sep 29, 2025 10:05am
GSK plots $30B investment in US manufacturing, R&D
Sep 16, 2025 7:01pm
Gilead breaks ground on production hub as part of $32B US outlay
Sep 3, 2025 2:36pm
Roche breaks ground on $700M N.C. manufacturing site
Aug 28, 2025 9:35am
Bayer is charting $43M in upgrades to API plant in Mexico
Aug 26, 2025 9:45am
Eli Lilly confirms plan to sell New Jersey plant
Aug 4, 2025 10:50am